|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arduino PG, Bagan J, El-Naggar AK and
Carrozzo M: Urban legends series: Oral leukoplakia. Oral Dis.
19:642–659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choudhari SK, Chaudhary M, Gadbail AR,
Sharma A and Tekade S: Oxidative and antioxidative mechanisms in
oral cancer and precancer: A review. Oral Oncol. 50:10–18. 2014.
View Article : Google Scholar
|
|
5
|
Zhang X, Han S, Han HY, Ryu MH, Kim KY,
Choi EJ, Cha IH and Kim J: Risk prediction for malignant conversion
of oral epithelial dysplasia by hypoxia related protein expression.
Pathology. 45:478–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dionne KR, Warnakulasuriya S, Zain RB and
Cheong SC: Potentially malignant disorders of the oral cavity:
Current practice and future directions in the clinic and
laboratory. Int J Cancer. 136:503–515. 2015.
|
|
7
|
Liu F, Zhang Y, Men T, Jiang X, Yang C, Li
H, Wei X, Yan D, Feng G, Yang J, et al: Quantitative proteomic
analysis of gastric cancer tissue reveals novel proteins in
platelet-derived growth factor b signaling pathway. Oncotarget.
8:22059–22075. 2017.PubMed/NCBI
|
|
8
|
Wang Z, Jiang L, Huang C, Li Z, Chen L,
Gou L, Chen P, Tong A, Tang M, Gao F, et al: Comparative proteomics
approach to screening of potential diagnostic and therapeutic
targets for oral squamous cell carcinoma. Mol Cell Proteomics.
7:1639–1650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qing S, Tulake W, Ru M, Li X, Yuemaier R,
Lidifu D, Rouzibilali A, Hasimu A, Yang Y, Rouziahong R, et al:
Proteomic identification of potential biomarkers for cervical
squamous cell carcinoma and human papillomavirus infection. Tumour
Biol. 39:1010428317697547. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dey KK, Pal I, Bharti R, Dey G, Kumar BN,
Rajput S, Parekh A, Parida S, Halder P, Kulavi I, et al:
Identification of RAB2A and PRDX1 as the potential biomarkers for
oral squamous cell carcinoma using mass spectrometry-based
comparative proteomic approach. Tumour Biol. 36:9829–9837. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hung KF, Liu CJ, Chiu PC, Lin JS, Chang
KW, Shih WY, Kao SY and Tu HF: MicroRNA-31 upregulation predicts
increased risk of progression of oral potentially malignant
disorder. Oral Oncol. 53:42–47. 2016. View Article : Google Scholar
|
|
12
|
Kanojia D and Vaidya MM:
4-nitroquinoline-1-oxide induced experimental oral carcinogenesis.
Oral Oncol. 42:655–667. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu T, Hong Y, Jia L, Wu J, Xia J, Wang J,
Hu Q and Cheng B: Modulation of IL-1β reprogrammes the tumor
microenvironment to interrupt oral carcinogenesis. Sci Rep.
6:202082016. View Article : Google Scholar
|
|
14
|
Lan A, Li W, Liu Y, Xiong Z, Zhang X, Zhou
S, Palko O, Chen H, Kapita M, Prigge JR, et al: Chemoprevention of
oxidative stress-associated oral carcinogenesis by sulforaphane
depends on NRF2 and the isothiocyanate moiety. Oncotarget.
7:53502–53514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li GZ, Liang HF, Liao B, Zhang L, Ni YA,
Zhou HH, Zhang EL, Zhang BX and Chen XP: PX-12 inhibits the growth
of hepatocelluar carcinoma by inducing S-phase arrest,
ROS-dependent apoptosis and enhances 5-FU cytotoxicity. Am J Transl
Res. 7:1528–1540. 2015.PubMed/NCBI
|
|
16
|
Hong Y, Yang L, Li C, Xia H, Rhodus NL and
Cheng B: Frequent mutation of p16(CDKN2A) exon 1 during rat tongue
carcinogenesis induced by 4-nitroquinoline-1-oxide. Mol Carcinog.
46:85–90. 2007. View
Article : Google Scholar
|
|
17
|
Jiang X, Wang J, Chen X, Hong Y, Wu T,
Chen X, Xia J and Cheng B: Elevated autocrine chemokine ligand 18
expression promotes oral cancer cell growth and invasion via Akt
activation. Oncotarget. 7:16262–16272. 2016.PubMed/NCBI
|
|
18
|
Hanschmann EM, Godoy JR, Berndt C,
Hudemann C and Lillig CH: Thioredoxins, glutaredoxins, and
peroxiredoxins - molecular mechanisms and health significance: From
cofactors to antioxidants to redox signaling. Antioxid Redox
Signal. 19:1539–1605. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Höckel M and Vaupel P: Tumor hypoxia:
Definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Hu Y, Xi N, Song J, Huang W, Song
S, Liu Y, Liu X and Xie Y: Partial oxygen pressure affects the
expression of prognostic biomarkers HIF-1 alpha, Ki67, and CK20 in
the microenvironment of colorectal cancer tissue. Oxid Med Cell
Longev. 2016:12047152016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng Y, Ni Y, Huang X, Wang Z and Han W:
Overexpression of HIF-1α indicates a poor prognosis in tongue
carcinoma and may be associated with tumour metastasis. Oncol Lett.
5:1285–1289. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Tu K, Wang Y, Yao B, Li Q, Wang L,
Dou C, Liu Q and Zheng X: Hypoxia accelerates aggressiveness of
hepatocellular carcinoma cells involving oxidative stress,
epithelial-mesenchymal transition and non-canonical hedgehog
signaling. Cell Physiol Biochem. 44:1856–1868. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noike T, Miwa S, Soeda J, Kobayashi A and
Miyagawa S: Increased expression of thioredoxin-1, vascular
endothelial growth factor, and redox factor-1 is associated with
poor prognosis in patients with liver metastasis from colorectal
cancer. Hum Pathol. 39:201–208. 2008. View Article : Google Scholar
|
|
24
|
Mishra R: Glycogen synthase kinase 3 beta:
Can it be a target for oral cancer. Mol Cancer. 9:1442010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou J, Schmid T, Schnitzer S and Brüne B:
Tumor hypoxia and cancer progression. Cancer Lett. 237:10–21. 2006.
View Article : Google Scholar
|
|
27
|
DE Lima PO, Jorge CC, Oliveira DT and
Pereira MC: Hypoxic condition and prognosis in oral squamous cell
carcinoma. Anticancer Res. 34:605–612. 2014.PubMed/NCBI
|
|
28
|
Kujan O, Shearston K and Farah CS: The
role of hypoxia in oral cancer and potentially malignant disorders:
A review. J Oral Pathol Med. 46:246–252. 2017. View Article : Google Scholar
|
|
29
|
Sahaf B, Söderberg A, Spyrou G, Barral AM,
Pekkari K, Holmgren A and Rosén A: Thioredoxin expression and
localization in human cell lines: Detection of full-length and
truncated species. Exp Cell Res. 236:181–192. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kakolyris S, Giatromanolaki A, Koukourakis
M, Powis G, Souglakos J, Sivridis E, Georgoulias V, Gatter KC and
Harris AL: Thioredoxin expression is associated with lymph node
status and prognosis in early operable non-small cell lung cancer.
Clin Cancer Res. 7:3087–3091. 2001.PubMed/NCBI
|
|
31
|
Zhu X, Huang C and Peng B: Overexpression
of thioredoxin system proteins predicts poor prognosis in patients
with squamous cell carcinoma of the tongue. Oral Oncol. 47:609–614.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li C, Thompson MA, Tamayo AT, Zuo Z, Lee
J, Vega F, Ford RJ and Pham LV: Over-expression of Thioredoxin-1
mediates growth, survival, and chemoresistance and is a druggable
target in diffuse large B-cell lymphoma. Oncotarget. 3:314–326.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bhatia M, McGrath KL, Di Trapani G,
Charoentong P, Shah F, King MM, Clarke FM and Tonissen KF: The
thioredoxin system in breast cancer cell invasion and migration.
Redox Biol. 8:68–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Powis G and Kirkpatrick DL: Thioredoxin
signaling as a target for cancer therapy. Curr Opin Pharmacol.
7:392–397. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roh JL, Jang H, Kim EH and Shin D:
Targeting of the glutathione, thioredoxin, and Nrf2 antioxidant
systems in head and neck cancer. Antioxid Redox Signal. 27:106–114.
2017. View Article : Google Scholar
|
|
36
|
You BR, Shin HR, Han BR and Park WH: PX-12
induces apoptosis in Calu-6 cells in an oxidative stress-dependent
manner. Tumour Biol. 36:2087–2095. 2015. View Article : Google Scholar
|
|
37
|
Di Meo S, Reed TT, Venditti P and Victor
VM: Harmful and beneficial role of ROS. Oxid Med Cell Longev.
2016:79091862016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen X, Lv Q, Hong Y, Chen X, Cheng B and
Wu T: IL-1β maintains the redox balance by regulating glutaredoxin
1 expression during oral carcinogenesis. J Oral Pathol Med.
46:332–339. 2017. View Article : Google Scholar
|
